KMT2A and breast carcinoma: The M, MLL-1, MLL-2 were examined using haemagglutinating and growth inhibition assays against human breast cancer MCF-7 cells, which showed that MLL-2 has significant haemagglutinating activity and an inhibitory effect on MCF-7 cell growth.